Abbott Molecular, Inc. recalls Alinity m Resp-4-Plex AMP Kit
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- There were reports of an increase in reactive negative controls and false positive results.
- Products
-
- Alinity m Resp-4-Plex AMP Kit
- Company
- Abbott Molecular, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution.
Nationwide
- Units affected
- 656 units
- About this recall
- Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the simultaneous qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens collected by a healthcare provider (HCP), or in anterior nasal swab specimens that are self-collected at a healthcare location, from individuals suspected by their HCP of respiratory viral infection consistent with COVID-19.